China Medical System Holdings Limited (HKG: 0867)

China Medical System Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	7,014	8,013	9,150	8,337	6,946	6,074
Revenue Growth (YoY)	-24.68%	-12.43%	9.75%	20.03%	14.36%	11.78%
Cost of Revenue	1,848	1,937	2,115	2,090	1,812	1,527
Gross Profit	5,167	6,076	7,036	6,247	5,134	4,546
Selling, General & Admin	3,272	3,168	3,358	2,981	2,304	2,145
Research & Development	224.97	195.13	125.43	114.76	66.52	45.05
Operating Expenses	3,497	3,363	3,483	3,096	2,371	2,190
Operating Income	1,669	2,713	3,552	3,151	2,763	2,356
Interest Expense	-46.69	-46.25	-49.09	-28.27	-27.52	-56.26
Interest & Investment Income	179.29	177.1	105.52	81.85	61.03	42
Earnings From Equity Investments	286.85	277.87	65.06	75.35	153.8	114.29
Currency Exchange Gain (Loss)	-40.14	31.54	-126.21	22.62	60.56	-18.85
Other Non Operating Income (Expenses)	-88.55	-46.82	127.48	58.57	33.24	58.24
EBT Excluding Unusual Items	1,960	3,106	3,675	3,361	3,044	2,495
Impairment of Goodwill	-	-	-60	-20	-170	-
Gain (Loss) on Sale of Investments	-60.75	-60.75	150.01	115.66	-0.57	-
Gain (Loss) on Sale of Assets	-0.27	-0.27	-0.4	-0.23	-0.15	-2.85
Asset Writedown	-171.49	-171.49	-2	-	-57.6	-4.73
Pretax Income	1,728	2,874	3,763	3,457	2,816	2,488
Income Tax Expense	355.63	489.34	486.66	431.33	260.39	532
Earnings From Continuing Operations	1,372	2,384	3,276	3,025	2,556	1,956
Minority Interest in Earnings	18.43	16.51	-17.2	-7.86	-25.3	5.02
Net Income	1,390	2,401	3,259	3,017	2,530	1,961
Net Income to Common	1,390	2,401	3,259	3,017	2,530	1,961
Net Income Growth	-58.88%	-26.33%	8.01%	19.25%	29.06%	5.99%
Shares Outstanding (Basic)	2,445	2,452	2,454	2,468	2,472	2,480
Shares Outstanding (Diluted)	2,445	2,452	2,454	2,468	2,472	2,480
Shares Change (YoY)	-0.28%	-0.08%	-0.56%	-0.17%	-0.35%	-0.23%
EPS (Basic)	0.57	0.98	1.33	1.22	1.02	0.79
EPS (Diluted)	0.57	0.98	1.33	1.22	1.02	0.79
EPS Growth	-58.77%	-26.27%	8.61%	19.45%	29.50%	6.24%
Free Cash Flow	1,863	2,475	3,535	2,471	2,654	2,518
Free Cash Flow Per Share	0.76	1.01	1.44	1.00	1.07	1.01
Dividend Per Share	0.229	0.392	0.534	0.491	0.414	0.315
Dividend Growth	-58.72%	-26.70%	8.84%	18.66%	31.20%	6.20%
Gross Margin	73.66%	75.82%	76.89%	74.93%	73.92%	74.85%
Operating Margin	23.80%	33.85%	38.82%	37.79%	39.78%	38.79%
Profit Margin	19.82%	29.96%	35.62%	36.19%	36.43%	32.28%
Free Cash Flow Margin	26.56%	30.89%	38.63%	29.63%	38.22%	41.45%
EBITDA	1,889	2,922	3,762	3,357	2,960	2,550
EBITDA Margin	26.93%	36.47%	41.11%	40.27%	42.62%	41.99%
D&A For EBITDA	219.82	209.3	209.08	206.05	197.06	194.5
EBIT	1,669	2,713	3,552	3,151	2,763	2,356
EBIT Margin	23.80%	33.85%	38.82%	37.79%	39.78%	38.79%
Effective Tax Rate	20.59%	17.03%	12.93%	12.48%	9.25%	21.39%

Source: S&P Capital IQ. Standard template. Financial Sources.